Basit öğe kaydını göster

dc.contributor.authorvan Luijtelaar, Annemarijke
dc.contributor.authorGreenwood, Bernadette Marie
dc.contributor.authorAhmed, Hashim Uddin
dc.contributor.authorBarqawi, Al Baha
dc.contributor.authorBarret, Éric
dc.contributor.authorBomers, Joyce G.R.
dc.contributor.authorBrausi, Maurizio
dc.contributor.authorChoyke, Peter L.
dc.contributor.authorCooperberg, Matthew R.
dc.contributor.authorEggener, Scott E.
dc.contributor.authorFeller, John Francis
dc.contributor.authorFrauscher, Ferdinand
dc.contributor.authorGeorge, Arvin Koruthu
dc.contributor.authorHindley, Richard Graham
dc.contributor.authorJenniskens, Sjoerd F.M.
dc.contributor.authorKlotz, Laurence
dc.contributor.authorKovacs, Gyoergy
dc.contributor.authorLindner, Uri
dc.contributor.authorLoeb, Stacy
dc.contributor.authorMargolis, Daniel Jason Aaron
dc.contributor.authorMarks, Leonard S.
dc.contributor.authorMay, Stuart
dc.contributor.authorMcClure, Timothy D.
dc.contributor.authorMontironi, Rodolfo
dc.contributor.authorNour, Sherif Gamal
dc.contributor.authorOto, Aytekin
dc.contributor.authorPolascik, Thomas James
dc.contributor.authorRastinehad, Ardeshir R.
dc.contributor.authorde Reyke, T. M.
dc.contributor.authorReijnen, Jeroen Sebastiaan
dc.contributor.authorde la Rosette, Jean J. M. C. H.
dc.contributor.authorSedelaar, John Pieter Michiel
dc.contributor.authorSperling, Dan S.
dc.contributor.authorWalser, Eric M.
dc.contributor.authorWard, John F.
dc.contributor.authorVillers, Arnauld A.
dc.contributor.authorGhai, Sangeet
dc.contributor.authorFütterer, Jürgen Jacobus
dc.date.accessioned10.07.201910:49:13
dc.date.accessioned2019-07-10T19:35:35Z
dc.date.available10.07.201910:49:14
dc.date.available2019-07-10T19:35:35Z
dc.date.issued2019en_US
dc.identifier.citationvan Luijtelaar, A., Greenwood, B. M., Ahmed, H. U., Barqawi, A. B., Barret, É., Bomers, J. G.R. ... Fütterer, J. J. (2019). Focal laser ablation as clinical treatment of prostate cancer: Report from a Delphi consensus project. World Journal of Urology, 37(10), 2147-2153. https://dx.doi.org/10.1007/s00345-019-02636-7en_US
dc.identifier.issn0724-4983
dc.identifier.urihttps://hdl.handle.net/20.500.12511/856
dc.identifier.urihttps://dx.doi.org/10.1007/s00345-019-02636-7
dc.description.abstractPurpose: To define the role of focal laser ablation (FLA) as clinical treatment of prostate cancer (PCa) using the Delphi consensus method. Methods: A panel of international experts in the field of focal therapy (FT) in PCa conducted a collaborative consensus project using the Delphi method. Experts were invited to online questionnaires focusing on patient selection and treatment of PCa with FLA during four subsequent rounds. After each round, outcomes were displayed, and questionnaires were modified based on the comments provided by panelists. Results were finalized and discussed during face-to-face meetings. Results: Thirty-seven experts agreed to participate, and consensus was achieved on 39/43 topics. Clinically significant PCa (csPCa) was defined as any volume Grade Group 2 [Gleason score (GS) 3+4]. Focal therapy was specified as treatment of all csPCa and can be considered primary treatment as an alternative to radical treatment in carefully selected patients. In patients with intermediate-risk PCa (GS 3+4) as well as patients with MRI-visible and biopsy-confirmed local recurrence, FLA is optimal for targeted ablation of a specific magnetic resonance imaging (MRI)-visible focus. However, FLA should not be applied to candidates for active surveillance and close follow-up is required. Suitability for FLA is based on tumor volume, location to vital structures, GS, MRI-visibility, and biopsy confirmation. Conclusion: Focal laser ablation is a promising technique for treatment of clinically localized PCa and should ideally be performed within approved clinical trials. So far, only few studies have reported on FLA and further validation with longer follow-up is mandatory before widespread clinical implementation is justified.en_US
dc.language.isoengen_US
dc.publisherSpringer Verlagen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.rightsAttribution 4.0 International*
dc.rights.urihttps://creativecommons.org/licenses/by/4.0/*
dc.subjectConsensusen_US
dc.subjectDelphien_US
dc.subjectFocal Laser Ablationen_US
dc.subjectLaser Focal Therapyen_US
dc.subjectProstate Canceren_US
dc.titleFocal laser ablation as clinical treatment of prostate cancer: Report from a Delphi consensus projecten_US
dc.typearticleen_US
dc.relation.ispartofWorld Journal of Urologyen_US
dc.departmentİstanbul Medipol Üniversitesi, Uluslararası Tıp Fakültesi, Cerrahi Tıp Bilimleri Bölümü, Üroloji Ana Bilim Dalıen_US
dc.authorid0000-0002-6308-1763en_US
dc.identifier.volume37en_US
dc.identifier.issue10en_US
dc.identifier.startpage2147en_US
dc.identifier.endpage2153en_US
dc.relation.publicationcategoryMakale - Uluslararası Hakemli Dergi - Kurum Öğretim Elemanıen_US
dc.identifier.doi10.1007/s00345-019-02636-7en_US
dc.identifier.wosqualityQ1en_US
dc.identifier.scopusqualityQ1en_US


Bu öğenin dosyaları:

Thumbnail

Bu öğe aşağıdaki koleksiyon(lar)da görünmektedir.

Basit öğe kaydını göster

info:eu-repo/semantics/openAccess
Aksi belirtilmediği sürece bu öğenin lisansı: info:eu-repo/semantics/openAccess